Markets are tanking on tariff fears, inflationary concerns and now fears of recession. “Given this is so uncertain and that ...

Jones Financial Companies Lllp raised its stake in Sanofi (NASDAQ:SNY – Free Report) by 55.0% during the 4th quarter, ...

We recently published a list of 10 Best Immunology Stocks To Buy Now. In this article, we are going to take a look at where ...

Sanofi (NASDAQ:SNY – Free Report) – Stock analysts at Zacks Research cut their Q3 2025 earnings estimates for shares of Sanofi in a research note issued to investors on Wednesday, March 5th.

(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi presented positive results ... author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew ...

Keybank National Association OH grew its stake in Sanofi (NASDAQ:SNY – Free Report) by 9.9% during the 4th quarter, Holdings Channel reports.The fund owned 10,105 shares of the company’s stock ...

Sanofi (NASDAQ:SNY) stands seventh among the best immunology stocks to buy now. It is a global healthcare company specializing in innovative medicines and vaccines across immunology, oncology ...

Sanofi (NASDAQ:SNY – Free Report) – Equities researchers at Zacks Research lowered their Q2 2025 earnings estimates for Sanofi in a report issued on Wednesday, March 5th. Zacks Research analyst K.

Days after the U.S. FDA cancelled an annual meeting to discuss the makeup of the following season's flu vaccine, FDA ...

While markets sink, Regeneron Pharmaceuticals (NASDAQ:REGN) is up about 4%, or $30 on the day. Helping, the company and Sanofi (NASDAQ:SNY) just posted positive results from a pivotal ADEPT Phase ...

In this article, we are going to take a look at where Sanofi (NASDAQ:SNY) stands against other best immunology stocks to buy now. Immunology is a rapidly advancing field with significant potential ...